Greene Heather R, Schwartzberg Lee S
West Cancer Center & Research Institute, Memphis, Tennessee.
J Adv Pract Oncol. 2020 Apr;11(3):266-270. doi: 10.6004/jadpro.2020.11.3.10. Epub 2020 Apr 1.
Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying and monitoring adverse events associated with PARP and immune checkpoint inhibitors at JADPRO Live 2019.
希瑟·R·格林（Heather R. Greene），护理学硕士、家庭执业护士、高级肿瘤临床执业护士（AOCNP®），以及李·S·施瓦茨伯格（Lee S. Schwartzberg），医学博士、美国内科医师学会会员（FACP），在2019年JADPRO直播活动中讨论了三阴性乳腺癌的当前及未来治疗前景，包括已批准治疗方法的最新及新出现的数据、正在研究的新型治疗选择，以及识别和监测与PARP和免疫检查点抑制剂相关不良事件的最佳实践。
